Back
56
46
68
Also listed as
ORRAF
OTC
Day Range
$9.46
$11.68
52-Week Range
$8.14
$11.68
Volume
100
50D / 200D Avg
$11.68
/
$10.21
Prev Close
$11.68
Price History
Financial Trends
Peer Comparison
vs Consumer Cyclical sector median (609 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 1.9 | 11.1 |
| P/B | 0.6 | 1.4 |
| ROE % | 39.0 | 10.7 |
| Net Margin % | 46.6 | 5.1 |
| Rev Growth 5Y % | -12.3 | 8.3 |
| D/E | 0.2 | 0.8 |
Key Takeaways
Revenue declined -12.33% annually over 5 years
Earnings grew 425.43% over the past year
ROE of 39.02% indicates high profitability
Net margin of 46.56% shows strong profitability
Debt/Equity of 0.23 — conservative balance sheet
Generating 106.10M in free cash flow
Growth
Revenue Growth (5Y)
-12.33%
Revenue (1Y)-55.50%
Earnings (1Y)425.43%
FCF Growth (3Y)32.32%
Quality
Return on Equity
39.02%
ROIC1.84%
Net Margin46.56%
Op. Margin4.17%
Safety
Debt / Equity
0.23
Current Ratio1.42
Interest Coverage1.21
Valuation
P/E Ratio
1.88
P/B Ratio0.63
EV/EBITDA25.47
Dividend Yield0.07%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -55.50% | Revenue Growth (3Y) | -30.21% |
| Earnings Growth (1Y) | 425.43% | Earnings Growth (3Y) | 129.47% |
| Revenue Growth (5Y) | -12.33% | Earnings Growth (5Y) | 63.61% |
| Profitability | |||
| Revenue (TTM) | 2.09B | Net Income (TTM) | 973.10M |
| ROE | 39.02% | ROA | 20.07% |
| Gross Margin | 23.09% | Operating Margin | 4.17% |
| Net Margin | 46.56% | Free Cash Flow (TTM) | 106.10M |
| ROIC | 1.84% | FCF Growth (3Y) | 32.32% |
| Safety | |||
| Debt / Equity | 0.23 | Current Ratio | 1.42 |
| Interest Coverage | 1.21 | Dividend Yield | 0.07% |
| Valuation | |||
| P/E Ratio | 1.88 | P/B Ratio | 0.63 |
| P/S Ratio | 0.87 | PEG Ratio | 0.01 |
| EV/EBITDA | 25.47 | Dividend Yield | 0.07% |
| Market Cap | 1.83B | Enterprise Value | 2.22B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.09B | 4.70B | 4.29B | 4.09B | 3.54B |
| Net Income | 973.10M | 185.20M | 184.80M | 184.70M | 135.80M |
| EPS (Diluted) | 7.30 | 1.50 | 2.00 | 2.20 | 1.40 |
| Gross Profit | 482.70M | 915.60M | 799.80M | 772.70M | 674.20M |
| Operating Income | 87.20M | 354.50M | 287.60M | 281.80M | 207.00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 4.85B | 5.99B | 2.90B | 2.78B | 2.39B |
| Total Liabilities | 1.95B | 3.90B | 2.09B | 2.04B | 1.62B |
| Shareholders' Equity | 2.90B | 2.09B | 800.20M | 731.70M | 768.60M |
| Total Debt | 653.30M | 2.42B | 1.06B | 906.10M | 756.30M |
| Cash & Equivalents | 257.40M | 274.70M | 58.40M | 52.60M | 50.60M |
| Current Assets | 1.32B | 1.93B | 1.26B | 1.31B | 980.80M |
| Current Liabilities | 933.70M | 1.22B | 1.08B | 1.12B | 806.30M |
Strategy Scores
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
#197 of 820
#186 of 658
#40 of 708
Recent Activity
Entered
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026
Entered
Defensive Investing (Benjamin Graham)
Mar 24, 2026